News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
Crypto Hedge Funds Face Stunning 2024 Struggle: Why Professional Investors Are Losing Ground
Bitcoinworld·2025/12/20 01:12
Peter Brandt Highlights Bearish XRP Price Chart, ‘You Need To Deal With It’
Newsbtc·2025/12/20 01:09
Explosive Growth: Grayscale Predicts 1,000x Surge for the Tokenized Asset Market by 2030
Bitcoinworld·2025/12/20 00:57
4 Best Cryptos Worth Buying as Altcoins Trade 30%–55% Below Cycle Highs
Cryptonewsland·2025/12/20 00:51
Bank of Japan rate hike to 0.75% tests global funding structures, Bitcoin stability
Crypto.News·2025/12/20 00:33
In the last 12 hours, 3 new addresses received 2509 BTC each from FalconX.
BlockBeats·2025/12/20 00:22
Hasset: U.S. Inflation Is Actually Below Target, Fed Has 'Plenty of Room' to Cut Rates
BlockBeats·2025/12/20 00:20
Citi Analysts Project Bitcoin Price Could Reach $189,000 Next Year In Bullish Scenario
Newsbtc·2025/12/20 00:03
You Need to Hold At Least 2,314 XRP. Here’s Why
TimesTabloid·2025/12/20 00:00
Flash
14:45
After its request for reconsideration was rejected by Nasdaq, Oriental Rise Holdings Ltd. is now seeking to appeal the exchange's delisting decision.The company's move aims to challenge the exchange's decision to uphold its delisting through a formal appeals process.
14:42
"Maji Big Brother" sold a Bored Ape NFT and used the proceeds to add margin to a Hyperliquid account.According to Foresight News, Arkham monitoring shows that "Machi Big Brother" sold one of his 150 Bored Ape holdings and used the proceeds to add margin to his Hyperliquid account. He now holds a $67,000 margin and has opened a $1.6 million ETH long position.
14:40
US stocks move: Eli Lilly surges over 6% to a record high as leukemia drug Jaypirca receives positive recommendation from the European Union’s CHMPGolden Globe June 26｜A certain exchange surged by more than 6%, reaching $1,200.55, marking a record high. In terms of news, the company announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended approval of its non-covalent Bruton’s tyrosine kinase (BTK) inhibitor Jaypirca, for the treatment of adult chronic lymphocytic leukemia (CLL) patients who have received or not received BTK inhibitor therapy. This recommendation covers the entire line of treatment for this indication.